Stocks › HQH
abrdn Healthcare Investors
HQH·NYSE·
United States·USD
United States·USD$19.33
-0.25 (-1.28%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
HQH
abrdn Healthcare Investors · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HQHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of HQH by members of U.S. Congress · 0 on record
No congressional trades in HQH on record.
Whale Activity
Position changes in HQH reported for 2026-06-30 by 2 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed2
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 0 | $0 | closed |
| Millennium Management LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by HQH insiders, by quarter · Form 4
Recent Insider Transactions
44 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Mahai Chris LaVictoireDirector · Director | Purchase | +501 | $20.96 | $11K | Jul 16, 2026 | Form 4 ↗ |
| DiMartino RoseDirector | Purchase | +1,000 | $18.88 | $19K | Jul 16, 2024 | Form 4 ↗ |
| Goetz KathleenDirector | Purchase | +525 | $16.42 | $9K | Apr 9, 2024 | Form 4 ↗ |
| Reit ToddDirector | Purchase | +1,000 | $16.93 | $17K | Jan 2, 2024 | Form 4 ↗ |
| Maher BillDirector | Purchase | +1,000 | $16.58 | $17K | Dec 28, 2023 | Form 4 ↗ |
| Goodson Alan RVice President | Purchase | +170 | $16.13 | $3K | Dec 21, 2023 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +9,500 | $15.63 | $148K | Sep 25, 2023 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +9,500 | $15.88 | $151K | Sep 20, 2023 | Form 4 ↗ |
| Goetz KathleenDirector | Purchase | +74 | $20.42 | $2K | Mar 23, 2022 | Form 4 ↗ |
| Goetz KathleenDirector | Purchase | +481 | $21.52 | $10K | Jan 26, 2022 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +5,200 | $20.53 | $107K | Oct 26, 2020 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +5,050 | $20.68 | $104K | Oct 21, 2020 | Form 4 ↗ |
| Bailey Jeffrey AllenDirector | Purchase | +490 | $20.39 | $10K | Sep 23, 2020 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +5,000 | $21.01 | $105K | May 21, 2020 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +6,800 | $16.24 | $110K | Mar 17, 2020 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +6,300 | $17.14 | $108K | Dec 26, 2018 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +5,500 | $20.43 | $112K | Oct 25, 2018 | Form 4 ↗ |
| OMSTEAD DANIEL RPresident · Director | Purchase | +3,882 | $21.78 | $85K | Oct 17, 2018 | Form 4 ↗ |
| Kent Thomas MDirector | Purchase | +1,100 | $24.19 | $27K | Jan 25, 2018 | Form 4 ↗ |
| Gasperoni Timothy L | Purchase | +862 | $28.98 | $25K | Jan 6, 2016 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding HQH · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Amplify CEF High Income ETF Amplify ETF Trust | 1.2M | $26.1M | 3.62% | Jun 30, 2026 |
| Cohen & Steers Closed-End Opportunity Fund, Inc. | 89.6K | $2.0M | 0.52% | Jun 30, 2026 |
| Modern Capital Tactical Income Fund Modern Capital Funds Trust | 75.6K | $1.7M | 2.45% | Jun 30, 2026 |
| First Trust Income Opportunities ETF First Trust Exchange-Traded Fund VIII | 38.4K | $768K | 0.97% | May 31, 2026 |
| Multi-Hedge Strategies Fund Rydex Variable Trust | 137 | $3K | 0.01% | Jun 30, 2026 |
| Guggenheim Multi-Hedge Strategies Fund Rydex Series Funds | 48 | $1K | 0.01% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list HQH's shares (CUSIP 87911J103), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming abrdn Healthcare Investors as client
No lobbying filings found naming abrdn Healthcare Investors as the client.
Government Contracts
Federal awards to abrdn Healthcare Investors · USAspending
No federal contract awards found for abrdn Healthcare Investors.
U.S. Patents
Recent USPTO applications naming abrdn Healthcare Investors
No USPTO patent applications found for abrdn Healthcare Investors.
Annual Financials
From HQH's 10-K filings · XBRL
No annual XBRL figures on record for HQH. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in HQH's price history.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About abrdn Healthcare Investors
From SEC EDGAR company records
HeadquartersPHILADELPHIA, PA
IncorporatedMA
SEC CIK0000805267 ↗
Former namesTEKLA HEALTHCARE INVESTORS, H&Q HEALTHCARE INVESTORS